Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer. In locally advanced (LA) HNSCC, a multidisciplinary approach consisting of surgery followed by chemoradiation (CRT) or definitive CRT is the mainstay of treatment. In recurrent metastatic (R/M), HNSCC immune checkpoint inhibitors (ICIs) with or without chemotherapy represent the new first-line option. However, cancer will recur in about two out of five patients with LA HNSCC. If progression occurs within six months from platin-radiotherapy treatment, anti-programmed cell death-1 (PD-1) may be prescribed. Otherwise, immunotherapy with or without chemotherapy might be considered if PD-L1 is expressed. Despite several improvements in the outcome of patients with R/M...
Chemoradiotherapy (CRT) is a standard treatment for advanced head and neck squamous cell carcinoma (...
The tumor microenvironment (TME) of head and neck squamous cell carcinoma (HNSCC) is comprised of ca...
The aim of this study was to determine the effect of HNSCC tumour treatment on systemic Th1 and Th2 ...
HNSCCs are the major progressive malignancy of the upper digestive and respiratory organs. Malignant...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide, account...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide, account...
Head and neck squamous cell carcinomas (HNSCCs) are aggressive diseases with a dismal patient progno...
Head and neck squamous cell cancer (HNSCC) is one of the ten most common malignant neoplasms, charac...
Head and neck squamous cell carcinoma (HNSCC) represents a heterogeneous group of tumors. While sign...
Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancer in the world. Despi...
According to the new determinants of cancer immunity, head and neck squamous cell cancer (HNSCC) has...
According to the new determinants of cancer immunity, head and neck squamous cell cancer (HNSCC) has...
Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically complex and difficult...
Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically complex and difficult...
Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically complex and difficult...
Chemoradiotherapy (CRT) is a standard treatment for advanced head and neck squamous cell carcinoma (...
The tumor microenvironment (TME) of head and neck squamous cell carcinoma (HNSCC) is comprised of ca...
The aim of this study was to determine the effect of HNSCC tumour treatment on systemic Th1 and Th2 ...
HNSCCs are the major progressive malignancy of the upper digestive and respiratory organs. Malignant...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide, account...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide, account...
Head and neck squamous cell carcinomas (HNSCCs) are aggressive diseases with a dismal patient progno...
Head and neck squamous cell cancer (HNSCC) is one of the ten most common malignant neoplasms, charac...
Head and neck squamous cell carcinoma (HNSCC) represents a heterogeneous group of tumors. While sign...
Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancer in the world. Despi...
According to the new determinants of cancer immunity, head and neck squamous cell cancer (HNSCC) has...
According to the new determinants of cancer immunity, head and neck squamous cell cancer (HNSCC) has...
Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically complex and difficult...
Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically complex and difficult...
Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically complex and difficult...
Chemoradiotherapy (CRT) is a standard treatment for advanced head and neck squamous cell carcinoma (...
The tumor microenvironment (TME) of head and neck squamous cell carcinoma (HNSCC) is comprised of ca...
The aim of this study was to determine the effect of HNSCC tumour treatment on systemic Th1 and Th2 ...